首页> 外文OA文献 >Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting
【2h】

Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting

机译:冠状动脉旁路移植术后免疫能力强的个体中与输血相关的移植物抗宿主疾病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transfusion associated graft versus host disease (TA-GVHD) is a rare but commonly fatal complication of transfusion of cellular blood products, which usually occurs in immunosuppressed individuals following transfusion and subsequent engraftment of viable T lymphocytes. Very rarely it may arise in apparently immunocompetent individuals. The clinical syndrome consists of fever, skin rash, diarrhoea, hepatic dysfunction, and bone marrow aplasia. The outcome is nearly always fatal. We present here a case report of fatal TA-GVHD in a “presumed” immunocompetent patient, post coronary artery bypass grafting surgery after transfusion of blood products. The patient died 24 days after transfusion.
机译:与输血相关的移植物抗宿主病(TA-GVHD)是一种罕见的但通常致命的细胞血液制品输注并发症,通常发生在输血及随后的活T淋巴细胞移植后的免疫抑制个体中。它在极具免疫能力的个体中极少出现。临床综合征包括发烧,皮疹,腹泻,肝功能不全和骨髓发育不良。结果几乎总是致命的。我们在此介绍一例“假定的”有免疫能力的患者在输血后进行冠状动脉搭桥手术后发生致命TA-GVHD的病例报告。该患者在输血后24天死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号